Ann: UPDATE ON HEPATITIS C TRIAL , page-20

Malmanu,

If you get a reply here is what I would expect it to say:

BNIKF shares cannot be tracked accurately by the company because of the way the OTC market works. Only approximate numbers for BNIKF are known.

BLT will move from the OTC board to NASDAQ. (This should fix the problem of the above.)

Still high level of institutional interest in the company.

Don't quote me on this but reading between the lines of various statements made by the company these are the conclusions that I have drawn.